Resultados de la búsqueda 1-10 of 14930 for Tyrosine

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  4. Enfermedad de Wilson

    Biochemical, enzymatic, and computational characterization of recurrent somatic mutations of the human protein tyrosine phosphatase PTP1B in primary mediastinal ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  9. Esclerosis múltiple

    Bruton tyrosine kinase inhibitors for multiple sclerosis. Nature Reviews Neurology. 2023; doi:10.1038/s41582-023-00800-7. Pediatric MS. National Multiple ...

  10. Programa de cáncer de pulmón - Ensayos clínicos - Mayo Clinic

    Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements are ...